- Home
- SLRC vs CDNA Comparison
SLRC vs CDNA Comparison
Compare SLRC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRC
- CDNA
- Stock Information
- Founded
- SLRC 2007
- CDNA 1998
- Country
- SLRC United States
- CDNA United States
- Employees
- SLRC N/A
- CDNA N/A
- Industry
- SLRC Finance/Investors Services
- CDNA Medical Specialities
- Sector
- SLRC Finance
- CDNA Health Care
- Exchange
- SLRC Nasdaq
- CDNA Nasdaq
- Market Cap
- SLRC 889.2M
- CDNA 1.0B
- IPO Year
- SLRC 2010
- CDNA 2014
- Fundamental
- Price
- SLRC $16.42
- CDNA $20.13
- Analyst Decision
- SLRC Hold
- CDNA Buy
- Analyst Count
- SLRC 6
- CDNA 6
- Target Price
- SLRC $15.79
- CDNA $30.33
- AVG Volume (30 Days)
- SLRC 244.9K
- CDNA 866.7K
- Earning Date
- SLRC 08-05-2025
- CDNA 07-30-2025
- Dividend Yield
- SLRC 10.02%
- CDNA N/A
- EPS Growth
- SLRC N/A
- CDNA N/A
- EPS
- SLRC 1.61
- CDNA 1.07
- Revenue
- SLRC $227,510,000.00
- CDNA $346,421,000.00
- Revenue This Year
- SLRC N/A
- CDNA $13.31
- Revenue Next Year
- SLRC N/A
- CDNA $15.46
- P/E Ratio
- SLRC $10.16
- CDNA $18.99
- Revenue Growth
- SLRC N/A
- CDNA 25.92
- 52 Week Low
- SLRC $13.64
- CDNA $14.09
- 52 Week High
- SLRC $17.94
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- SLRC 54.50
- CDNA 58.32
- Support Level
- SLRC $16.15
- CDNA $18.37
- Resistance Level
- SLRC $16.45
- CDNA $20.91
- Average True Range (ATR)
- SLRC 0.25
- CDNA 0.80
- MACD
- SLRC 0.02
- CDNA 0.06
- Stochastic Oscillator
- SLRC 95.38
- CDNA 69.88
About SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.